Pharmacological treatment for keloids

Bibliography

• Ogawa R. Keloids as a serious disease such as malignancy. Plast Reconstr Surg 2008;122:993-4
   Google Scholar
• Huang C, Akaishi S, Hyakusoku H, et al. Are keloid and hypertrophic scar different forms of the same disorder? A fibroproliferative skin disorder hypothesis based on keloid findings. Int Wound J 2012; doi: 10.1111/j.1742-481X.2012.01118.x
   Web of Science ®Google Scholar
• Huang C, Murphy GF, Akaishi S, et al. Keloids and Hypertrophic Scars: update and Future Directions. Plast Reconstr Surg Glob Open 2013;1:e25
   PubMedGoogle Scholar
• Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg 2010;125(2):557-68
   PubMed Web of Science ®Google Scholar
• Ogawa R, Arima J, Ono S, et al. Total management of a severe case of systemic keloids associated with high blood pressure (hypertension): clinical symptoms of keloids may be aggravated by hypertension. Eplasty 2013;13:e25
   Google Scholar
• Arima J, Ogawa R, Iimura T, et al. Relationship between keloid and hypertension. J Nippon Med Sch 2012;79:494-5
   Google Scholar
• Ardekani GS, Aghaei S, Nemati MH, et al. Treatment of a postburn keloid scar with topical captopril: report of the first case. Plast Reconstr Surg 2009;123:112e-3e
   PubMedGoogle Scholar
• Iannello S, Milazzo P, Bordonaro F, et al. Low-dose enalapril in the treatment of surgical cutaneous hypertrophic scar and keloid–two case reports and literature review. Med Gen Med 2006;8:60
   PubMedGoogle Scholar
• D'Andrea F, Brongo S, Ferraro G, et al. Prevention and treatment of keloids with intralesional verapamil. Dermatology 2002;204:60-2
   PubMed Web of Science ®Google Scholar
• Copcu E, Sivrioglu N, Oztan Y. Combination of surgery and intralesional verapamil injection in the treatment of the keloid. J Burn Care Rehabil 2004;25:1-7
   PubMedGoogle Scholar
• Moustafa MF, Abdel-Fattah MA, Abdel-Fattah DC. Presumptive evidence of the effect of pregnancy estrogens on keloid growth. Case report. Plast Reconstr Surg 1975;56:450-3
   PubMedGoogle Scholar
• Chau D, Mancoll JS, Lee S, et al. Tamoxifen downregulates TGF-beta production in keloid fibroblasts. Ann Plast Surg 1998;40:490-3
   PubMed Web of Science ®Google Scholar
• Mousavi SR, Raaiszadeh M, Aminseresht M, et al. Evaluating tamoxifen effect in the prevention of hypertrophic scars following surgical incisions. Dermatol Surg 2010;36:665-9
   Google Scholar
• George AO, Akanji AO, Nduka EU, et al. Clinical, biochemical and morphologic features of acne keloidalis in a black population. Int J Dermatol 1993;32:714-16
   PubMedGoogle Scholar
• Schierle HP, Scholz D, Lemperle G. Elevated levels of testosterone receptors in keloid tissue: an experimental investigation. Plast Reconstr Surg 1997;100:390-5
   Google Scholar
• Ford LC, King DF, Lagasse LD, et al. Increased androgen binding in keloids: a preliminary communication. J Dermatol Surg Oncol 1983;9:545-7
   Google Scholar
• Louw L, Engelbrecht AM, Cloete F, et al. Impairment in the fatty acid composition of keloids. Adv Exp Med Biol 1997;400B:905-10
   Google Scholar
• Louw L, Dannhauser A. Keloids in rural black South Africans. Part 2: dietary fatty acid intake and total phospholipid fatty acid profile in the blood of keloid patients. Prostaglandins Leukot Essent Fatty Acids 2000;63:247-53
   Google Scholar
• Huang C, Ogawa R. Roles of lipid metabolism in keloid development. Lipids Health Dis 2013;12:60
   Google Scholar
• Louw L. Keloids in rural black South Africans. Part 1: general overview and essential fatty acid hypotheses for keloid formation and prevention. Prostaglandins Leukot Essent Fatty Acids 2000;63:237-45
   Google Scholar
• Louw L. Keloids in rural black South Africans. Part 3: a lipid model for the prevention and treatment of keloid formations. Prostaglandins Leukot Essent Fatty Acids 2000;63:255-62
   Google Scholar
• Datubo-Brown DD, Blight A. Inhibition of human fibroblast growth in vitro by a snake oil. Br J Plast Surg 1990;43:183-6
   Google Scholar
• Zampieri N, Zuin V, Burro R, et al. A prospective study in children: pre- and post-surgery use of vitamin E in surgical incisions. J Plast Reconstr Aesthet Surg 2010;63:1474-8
   Google Scholar
• Zhang GY, Cheng T, Luan Q, et al. Vitamin D: a novel therapeutic approach for keloid, an in vitro analysis. Br J Dermatol 2011;164:729-37
   Google Scholar
• Ueda K, Furuya E, Yasuda Y, et al. Keloids have continuous high metabolic activity. Plast Reconstr Surg 1999;104:694-8
   PubMed Web of Science ®Google Scholar
• Ichioka S, Ando T, Shibata M, et al. Oxygen consumption of keloids and hypertrophic scars. Ann Plast Surg 2008;60:194-7
   PubMed Web of Science ®Google Scholar
• Weber L, Meigel WN, Spier W. Collagen polymorphism in pathologic human scars. Arch Dermatol Res 1978;261:63-71
   PubMed Web of Science ®Google Scholar
• Dolynchuk KN, Bendor-Samuel R, Bowness JM. Effect of putrescine on tissue transglutaminase activity in wounds: decreased breaking strength and increased matrix fucoprotein solubility. Plast Reconstr Surg 1994;93:567-73
   Google Scholar
• Dolynchuk KN, Ziesmann M, Serletti JM. Topical putrescine (Fibrostat) in treatment of hypertrophic scars: phase II study. Plast Reconstr Surg 1996;97:117-23
   PubMed Web of Science ®Google Scholar
• Robles DT, Moore E, Draznin M, et al. Kloids: pathophysiology and management. Dermatol Online J 2007;13:9
   PubMedGoogle Scholar
• Jalali M, Bayat A. Current use of steroids in management of abnormal raised skin scars. Surgeon 2007;5:175-80
   PubMed Web of Science ®Google Scholar
• Mustoe TA, Cooter RD, Gold MH, et al. International clinical recommendations on scar management. Plast Reconstr Surg 2002;110:560-71
   PubMed Web of Science ®Google Scholar
• Ritota PC, Lo AK. Cushing's syndrome in postburn children following intralesional triamcinolone injection. Ann Plast Surg 1996;36:508-11
   PubMed Web of Science ®Google Scholar
• Niessen FB, Spauwen PH, Schalkwijk J, et al. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999;104:1435-58
   PubMed Web of Science ®Google Scholar
• Russell JD, Russell SB, Trupin KM. Differential effects of hydrocortisone on both growth and collagen metabolism of human fibroblasts from normal and keloid tissue. J Cell Physiol 1978;97:221-9
   PubMed Web of Science ®Google Scholar
• Russell SB, Trupin JS, Kennedy RZ, et al. Glucocorticoid regulation of elastin synthesis in human fibroblasts: down-regulation in fibroblasts from normal dermis but not from keloids. J Invest Dermatol 1995;104:241-5
   Google Scholar
• Syed F, Bayat A. Superior effect of combination vs. single steroid therapy in keloid disease: a comparative in vitro analysis of glucocorticoids. Wound Repair Regen 2013;21:88-102
   Google Scholar
• Saito M, Yamazaki M, Maeda T, et al. Pirfenidone suppresses keloid fibroblast-embedded collagen gel contraction. Arch Dermatol Res 2012;304:217-22
   Google Scholar
• Gancedo M, Ruiz-Corro L, Salazar-Montes A, et al. Pirfenidone prevents capsular contracture after mammary implantation. Aesthetic Plast Surg 2008;32:32-40
   PubMed Web of Science ®Google Scholar
• Oku H, Shimizu T, Kawabata T, et al. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Eur J Pharmacol 2008;590:400-8
   PubMed Web of Science ®Google Scholar
• Shetlar MR, Shetlar DJ, Bloom RF, et al. Involution of keloid implants in athymic mice treated with pirfenidone or with triamcinolone. J Lab Clin Med 1998;132:491-6
   Google Scholar
• Armendariz-Borunda J, Lyra-Gonzalez I, Medina-Preciado D, et al. A controlled clinical trial with pirfenidone in the treatment of pathological skin scarring caused by burns in pediatric patients. Ann Plast Surg 2012;68:22-8
   PubMed Web of Science ®Google Scholar
• Shmoilov AM, Rudenskaya GN, Isaev VA, et al. A comparative study of collagenase complex and new homogeneous collagenase preparations for scar treatment. J Drug Deliv Sci Technol 2006;16:285-92
   Google Scholar
• Kang N, Sivakumar B, Sanders R, et al. Intra-lesional injections of collagenase are ineffective in the treatment of keloid and hypertrophic scars. J Plast Reconstr Aesthet Surg 2006;59:693-9
   Google Scholar
• Lopes LB, Furnish EJ, Komalavilas P, et al. Cell permeant peptide analogues of the small heat shock protein, HSP20, reduce TGF-beta1-induced CTGF expression in keloid fibroblasts. J Invest Dermatol 2009;129:590-8
   PubMed Web of Science ®Google Scholar
• Flynn CR, Cheung-Flynn J, Smoke CC, et al. Internalization and intracellular trafficking of a PTD-conjugated anti-fibrotic peptide, AZX100, in human dermal keloid fibroblasts. J Pharm Sci 2010;99:3100-21
   PubMed Web of Science ®Google Scholar
• Huang L, Wong YP, Cai YJ, et al. Low-dose 5-fluorouracil induces cell cycle G2 arrest and apoptosis in keloid fibroblasts. Br J Dermatol 2010;163:1181-5
   Google Scholar
• Gupta S, Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology 2002;204:130-2
   PubMed Web of Science ®Google Scholar
• Nanda S, Reddy BS. Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg 2004;30:54-6
   PubMed Web of Science ®Google Scholar
• Khare N, Patil SB. A novel approach for management of ear keloids: results of excision combined with 5-fluorouracil injection. J Plast Reconstr Aesthet Surg 2012;65:e315-17
   Google Scholar
• Haurani MJ, Foreman K, Yang JJ, et al. 5-Fluorouracil treatment of problematic scars. Plast Reconstr Surg 2009;123:139-48
   PubMed Web of Science ®Google Scholar
• Darougheh A, Asilian A, Shariati F. Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. Clin Exp Dermatol 2009;34:219-23
   PubMed Web of Science ®Google Scholar
• Seo SH, Sung HW. Treatment of keloids and hypertrophic scars using topical and intralesional mitomycin C. J Eur Acad Dermatol Venereol 2012;26:634-8
   Google Scholar
• Simman R, Alani H, Williams F. Effect of mitomycin C on keloid fibroblasts: an in vitro study. Ann Plast Surg 2003;50:71-6
   Google Scholar
• Gupta M, Narang T. Role of mitomycin C in reducing keloid recurrence: patient series and literature review. J Laryngol Otol 2011;125:297-300
   Google Scholar
• Chi SG, Kim JY, Lee WJ, et al. Ear keloids as a primary candidate for the application of mitomycin C after shave excision: in vivo and in vitro study. Dermatol Surg 2011;37:168-75
   Google Scholar
• Naeini FF, Najafian J, Ahmadpour K. Bleomycin tattooing as a promising therapeutic modality in large keloids and hypertrophic scars. Dermatol Surg 2006;32:1023-9
   PubMed Web of Science ®Google Scholar
• Barlogie B, Drewinko B, Schumann J, et al. Pulse cytophotometric analysis of cell cycle perturbation with bleomycin in vitro. Cancer Res 1976;36:1182-7
   PubMed Web of Science ®Google Scholar
• Hamilton RF Jr, Li L, Felder TB, et al. Bleomycin induces apoptosis in human alveolar macrophages. Am J Physiol 1995;269:L318-25
   Web of Science ®Google Scholar
• Yamamoto T. Bleomycin and the skin. Br J Dermatol 2006;155:869-75
   PubMed Web of Science ®Google Scholar
• España A, Solano T, Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg 2001;27:23-7
   PubMed Web of Science ®Google Scholar
• Aggarwal H, Saxena A, Lubana PS, et al. Treatment of keloids and hypertrophic scars using bleom. J Cosmet Dermatol 2008;7:43-9
   Google Scholar
• Oikarinen H, Oikarinen AI, Tan EM, et al. Modulation of procollagen gene expression by retinoids. Inhibition of collagen production by retinoic acid accompanied by reduced type I procollagen messenger ribonucleic acid levels in human skin fibroblast cultures. J Clin Invest 1985;75:1545-53
   PubMed Web of Science ®Google Scholar
• Uchida G, Yoshimura K, Kitano Y, et al. Tretinoin reverses upregulation of matrix metalloproteinase-13 in human keloid-derived fibroblasts. Exp Dermatol 2003;12(Suppl 2):35-42
   Google Scholar
• Abergel RP, Meeker CA, Oikarinen H, et al. Retinoid modulation of connective tissue metabolism in keloid fibroblast cultures. Arch Dermatol 1985;121:632-5
   PubMed Web of Science ®Google Scholar
• Daly TJ, Weston WL. Retinoid effects on fibroblast proliferation and collagen synthesis in vitro and on fibrotic disease in vivo. J Am Acad Dermatol 1986;15:900-2
   PubMed Web of Science ®Google Scholar
• Taylor EW. The mechanism of colchicine inhibition of mitosis: I. Kinetics of inhibition and the binding of H3-colchicine. J Cell Biol 1965;25(Suppl):145-60
   Google Scholar
• Bauer EA, Valle KJ. Colchicine-induced modulation of collagenase in human skin fibroblast cultures. I. Stimulation of enzyme synthesis in normal cells. J Invest Dermatol 1982;79:398-402
   PubMed Web of Science ®Google Scholar
• Sigler A. Use of colchicine to prevent recurrence of ear keloids. A new approach. J Plast Reconstr Aesthet Surg 2010;63:e650-2
   Google Scholar
• Kristensen BW, Noer H, Gramsbergen JB, et al. Colchicine induces apoptosis in organotypic hippocampal slice cultures. Brain Res 2003;964:264-78
   PubMedGoogle Scholar
• Quaglino D Jr, Nanney LB, Ditesheim JA, et al. Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: incisional wound model. J Invest Dermatol 1991;97:34-42
   PubMed Web of Science ®Google Scholar
• Massagué J, Attisano L, Wrana JL. The TGF-beta family and its composite receptors. Trends Cell Biol 1994;4:172-8
   PubMedGoogle Scholar
• Massagué J, Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 2000;19:1745-54
   PubMed Web of Science ®Google Scholar
• Sadick H, Herberger A, Riedel K, et al. TGF-beta1 antisense therapy modulates expression of matrix metalloproteinases in keloid-derived fibroblasts. Int J Mol Med 2008;22:55-60
   Google Scholar
• Bran GM, Goessler UR, Baftiri A, et al. Effect of transforming growth factor-beta1 antisense oligonucleotides on matrix metalloproteinases and their inhibitors in keloid fibroblasts. Otolaryngol Head Neck Surg 2010;143(1):66-71
   Google Scholar
• Bran GM, Sommer UJ, Goessler UR, et al. TGF-ß1 antisense impacts the SMAD signalling system in fibroblasts from keloid scars. Anticancer Res 2010;30:3459-63
   Google Scholar
• Jin SE, Kim CK, Kim YB. Cellular delivery of cationic lipid nanoparticle-based SMAD3 antisense oligonucleotides for the inhibition of collagen production in keloid fibroblasts. Eur J Pharm Biopharm 2012;82:19-26
   PubMed Web of Science ®Google Scholar
• Shah M, Foreman DM, Ferguson MW. Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 1992;339:213-14
   PubMed Web of Science ®Google Scholar
• Shah M, Foreman DM, Ferguson MW. Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 1994;107:1137-57
   PubMed Web of Science ®Google Scholar
• Dai C, Liu Y. Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. J Am Soc Nephrol 2004;15:1402-12
   PubMed Web of Science ®Google Scholar
• Ono I, Yamashita T, Hida T, et al. Local administration of hepatocyte growth factor gene enhances the regeneration of dermis in acute incisional wounds. J Surg Res 2004;120:47-55
   PubMed Web of Science ®Google Scholar
• Ferguson MW, Duncan J, Bond J, et al. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, Phase I/II studies. Lancet 2009;373:1264-74
   PubMed Web of Science ®Google Scholar
• Tiede S, Ernst N, Bayat A, et al. Basic fibroblast growth factor: a potential new therapeutic tool for the treatment of hypertrophic and keloid scars. Ann Anat 2009;191:33-44
   Google Scholar
• Akasaka Y, Ono I, Yamashita T, et al. Basic fibroblast growth factor promotes apoptosis and suppresses granulation tissue formation in acute incisional wounds. J Pathol 2004;203(2):710-20
   Google Scholar
• Ono I. The effects of basic fibroblast growth factor (bFGF) on the breaking strength of acute incisional wounds. J Dermatol Sci 2002;29:104-13
   PubMed Web of Science ®Google Scholar
• Ono I, Akasaka Y, Kikuchi R, et al. Basic fibroblast growth factor reduces scar formation in acute incisional wounds. Wound Repair Regen 2007;15:617-23
   Google Scholar
• Mogili NS, Krishnaswamy VR, Jayaraman M, et al. Altered angiogenic balance in keloids: a key to therapeutic intervention. Transl Res 2012;159:182-9
   PubMed Web of Science ®Google Scholar
• Gira AK, Brown LF, Washington CV, et al. Keloids demonstrate high-level epidermal expression of vascular endothelial growth factor. J Am Acad Dermatol 2004;50:850-3
   PubMed Web of Science ®Google Scholar
• Zhang GY, Yi CG, Li X, et al. Inhibition of vascular endothelial growth factor expression in keloid fibroblasts by vector-mediated vascular endothelial growth factor shRNA: a therapeutic potential strategy for keloid. Arch Dermatol Res 2008;300:177-84
   PubMed Web of Science ®Google Scholar
• Kim A, DiCarlo J, Cohen C, et al. Are keloids really “gli-loids”?: high-level expression of gli-1 oncogene in keloids. J Am Acad Dermatol 2001;45:707-11
   Google Scholar
• Wu CS, Wu PH, Fang AH, et al. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-beta1 on collagen expression and TGF-beta/Smad signalling in keloid fibroblasts: implication for new therapeutic approach. Br J Dermatol 2012;167:532-41
   PubMed Web of Science ®Google Scholar
• Gisquet H, Liu H, Blondel WC, et al. Intradermal tacrolimus prevent scar hypertrophy in a rabbit ear model: a clinical, histological and spectroscopical analysis. Skin Res Technol 2011;17:160-6
   Google Scholar
• Takeuchi K, Nakazawa M, Ebina Y, et al. Inhibitory effects of trehalose on fibroblast proliferation and implications for ocular surgery. Exp Eye Res 2010;91:567-77
   Google Scholar
• Sahara K, Kucukcelebi A, Ko F, et al. Suppression of in vitro proliferative scar fibroblast contraction by interferon alfa-2b. Wound Repair Regen 1993;1:22-7
   Google Scholar
• Berman B, Flores F. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J Am Acad Dermatol 1997;37:755-7
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim SE, Lee AY. Effects of interferon-alpha2b on keloid treatment with triamcinolone acetonide intralesional injection. Int J Dermatol 2008;47(2):183-6
   Google Scholar
• al-Khawajah MM. Failure of interferon-alpha 2b in the treatment of mature keloids. Int J Dermatol 1996;35:515-17
   Google Scholar
• Davison SP, Mess S, Kauffman LC, et al. Ineffective treatment of keloids with interferon alpha-2b. Plast Reconstr Surg 2006;117:247-52
   PubMedGoogle Scholar
• Ghosh AK, Yuan W, Mori Y, et al. Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators. J Biol Chem 2001;276:11041-8
   PubMed Web of Science ®Google Scholar
• Hasegawa T, Nakao A, Sumiyoshi K, et al. IFN-gamma fails to antagonize fibrotic effect of TGF-beta on keloid-derived dermal fibroblasts. J Dermatol Sci 2003;32:19-24
   PubMed Web of Science ®Google Scholar
• Granstein RD, Rook A, Flotte TJ, et al. A controlled trial of intralesional recombinant interferon-gamma in the treatment of keloidal scarring. Clinical and histologic findings. Arch Dermatol 1990;126:1295-302
   PubMedGoogle Scholar
• Broker BJ, Rosen D, Amsberry J, et al. Keloid excision and recurrence prophylaxis via intradermal interferon-gamma injections: a pilot study. Laryngoscope 1996;106:1497-501
   PubMedGoogle Scholar
• Berman B, Villa A. Imiquimod 5% cream for keloid management. Dermatol Surg 2003;29:1050-1
   PubMed Web of Science ®Google Scholar
• Jacob SE, Berman B, Nassiri M, et al. Topical application of imiquimod 5% cream to keloids alters expression genes associated with apoptosis. Br J Dermatol 2003;149(Suppl 66):62-5
   Google Scholar
• Stashower ME. Successful treatment of earlobe keloids with imiquimod after tangential shave excision. Dermatol Surg 2006;32:380-6
   PubMed Web of Science ®Google Scholar
• Malhotra AK, Gupta S, Khaitan BK, et al. Imiquimod 5% cream for the prevention of recurrence after excision of presternal keloids. Dermatology 2007;215:63-5
   PubMedGoogle Scholar
• Cação FM, Tanaka V, Messina MC. Failure of imiquimod 5% cream to prevent recurrence of surgically excised trunk keloids. Dermatol Surg 2009;35:629-33
   PubMed Web of Science ®Google Scholar
• Berman B, Harrison-Balestra C, Perez OA, et al. Treatment of keloid scars post-shave excision with imiquimod 5% cream: a prospective, double-blind, placebo-controlled pilot study. J Drugs Dermatol 2009;8:455-8
   PubMedGoogle Scholar
• Peranteau WH, Zhang L, Muvarak N, et al. IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. J Invest Dermatol 2008;128:1852-60
   PubMed Web of Science ®Google Scholar
• Ghazizadeh M, Tosa M, Shimizu H, et al. Functional implications of the IL-6 signaling pathway in keloid pathogenesis. J Invest Dermatol 2007;127:98-105
   PubMed Web of Science ®Google Scholar
• Gallucci RM, Simeonova PP, Matheson JM, et al. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J 2000;14:2525-31
   PubMed Web of Science ®Google Scholar
• Lin ZQ, Kondo T, Ishida Y, et al. Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J Leukoc Biol 2003;73:713-21
   PubMed Web of Science ®Google Scholar
• Suzawa H, Kikuchi S, Ichikawa K, et al. Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages. Jpn J Pharmacol 1992;60:85-90
   PubMedGoogle Scholar
• Inoue H, Ohshima H, Kono H, et al. Suppressive effects of tranilast on the expression of inducible cyclooxygenase (COX2) in interleukin-1beta-stimulated fibroblasts. Biochem Pharmacol 1997;53:1941-4
   PubMed Web of Science ®Google Scholar
• Suzawa H, Kikuchi S, Arai N, et al. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts. Jpn J Pharmacol 1992;60:91-6
   PubMedGoogle Scholar
• Yamada H, Tajima S, Nishikawa T, et al. Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts. J Biochem 1994;116:892-7
   Google Scholar
• Shigeki S, Murakami T, Yata N, et al. Treatment of keloid and hypertrophic scars by iontophoretic transdermal delivery of tranilast. Scand J Plast Reconstr Surg Hand Surg 1997;31:151-8
   PubMed Web of Science ®Google Scholar
• Fukuda K, Chikama T, Takahashi M, et al. Long-term follow-up after lamellar keratoplasty in a patient with bilateral idiopathic corneal keloid. Cornea 2011;30:1491-4
   Google Scholar
• Ogawa R, Hyakusoku H, Ogawa K, et al. Effectiveness of mugwort lotion for the treatment of post-burn hypertrophic scars. J Plast Reconstr Aesthet Surg 2008;61:210-12
   Google Scholar
• Chua AW, Gan SU, Ting Y, et al. Keloid fibroblasts are more sensitive to Wnt3a treatment in terms of elevated cellular growth and fibronectin expression. J Dermatol Sci 2011;64:199-209
   PubMed Web of Science ®Google Scholar
• Phan TT, Lim IJ, Chan SY, et al. Suppression of transforming growth factor beta/smad signaling in keloid-derived fibroblasts by quercetin: implications for the treatment of excessive scars. J Trauma 2004;57:1032-7
   PubMed Web of Science ®Google Scholar
• Phan TT, See P, Tran E, et al. Suppression of insulin-like growth factor signalling pathway and collagen expression in keloid-derived fibroblasts by quercetin: its therapeutic potential use in the treatment and/or prevention of keloids. Br J Dermatol 2003;148:544-52
   Google Scholar
• Phan TT, Lim IJ, Sun L, et al. Quercetin inhibits fibronectin production by keloid-derived fibroblasts. Implication for the treatment of excessive scars. J Dermatol Sci 2003;33:192-4
   Google Scholar
• Saulis AS, Mogford JH, Mustoe TA. Effect of Mederma on hypertrophic scarring in the rabbit ear model. Plast Reconstr Surg 2002;110:177-83
   PubMed Web of Science ®Google Scholar
• Campanati A, Savelli A, Sandroni L, et al. Effect of allium cepa-allantoin-pentaglycan gel on skin hypertrophic scars: clinical and video-capillaroscopic results of an open-label, controlled, nonrandomized clinical trial. Dermatol Surg 2010;36:1439-44
   PubMed Web of Science ®Google Scholar
• Uyesugi B, Lippincott B, Dave S. Treatment of a painful keloid with botulinum toxin type A. Am J Phys Med Rehabil 2010;89:153-5
   Google Scholar
• Zhibo X, Miaobo Z. Intralesional botulinum toxin type A injection as a new treatment measure for keloids. Plast Reconstr Surg 2009;124:275e-7e
   PubMed Web of Science ®Google Scholar
• Gauglitz GG, Bureik D, Dombrowski Y, et al. Botulinum toxin A for the treatment of keloids. Skin Pharmacol Physiol 2012;25:313-18
   PubMed Web of Science ®Google Scholar
• Hattori T, Matsunaga S, Nakazono Y, et al. Inhibition of nifedipine-induced proliferation of cultured human gingival fibroblasts by Saiko, a Chinese herbal medicine. Phytother Res 2006;20:704-7
   Google Scholar
• Ogawa R. Treatment of surgical site infection and hypertrophic scars. Kyobu Geka 2012;65:409-17
   Google Scholar
• Huang C, Ogawa R. Fibroproliferative disorders and their mechanobiology. Connect Tissue Res 2012;53:187-96
   PubMed Web of Science ®Google Scholar
• Ogawa R, Okai K, Tokumura F, et al. The relationship between skin stretching/contraction and pathologic scarring: the important role of mechanical forces in keloid generation. Wound Repair Regen 2012;20:149-57
   Google Scholar
• Huang C, Holfeld J, Schaden W, et al. Mechanotherapy: revisiting physical therapy and recruiting mechanobiology for a new era in medicine. Trends Mol Med 2013; pii: S1471-4914(13)00092-0. doi: 10.1016/j.molmed.2013.05.005
   Google Scholar
• Ogawa R. The latest in keloid and hypertrophic scar pathophysiology and treatment strategies: keloids can be treated by employing up-to-date surgical management. Plastic Surgery Pulse News 5. 2013. Available from: http://www.plasticsurgerypulsenews.com/14/article_dtl.php?QnCategoryID=136&QnArticleID=285
   Google Scholar